Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
D000293:Adolescent; D000328:Adult; D000347:Afibrinogenemia / Q000139:chemically induced*; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced; D005166:Factor V Deficiency / Q000139:chemically induced; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D002836:Hemophilia B / Q000139:chemically induced; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D010958:Plasminogen / Q000032:analysis; D012075:Remission, Spontaneous; D012709:Serum Albumin / Q000032:analysis
D001779:Blood Coagulation Factors; D012709:Serum Albumin; D010958:Plasminogen; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001215:Asparaginase